Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Scheltens

Showing results (31-40 of 266) with videos related to

Pageof 27
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1994
Visual rating of hippocampal atrophy: correlation with volumetryP Vermersch, D Leys, P Scheltens, et al.
Acta Neurologica Scandinavica|September 1, 1990
A Dutch family with autosomal dominant pure spastic paraparesis (Strümpell's disease)P Scheltens, R P Bruyn, G J Hazenberg
Journal of Neurology, Neurosurgery, and Psychiatry|August 19, 2005
Progression of cerebral white matter lesions in Alzheimer's disease: a new window for therapy?F-E de Leeuw, F Barkhof, P Scheltens
European Journal of Neurology|August 8, 2009
Use of cerebrospinal fluid biomarkers in diagnosis of dementia across EuropeJ Hort, A Bartos, T Pirttilä, et al.
AJNR. American Journal of Neuroradiology|January 1, 1992
Meningeal Gd-DTPA enhancement in multiple sclerosisF Barkhof, J Valk, O R Hommes, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 19, 1990
[Vascular dementia]P Scheltens, F Barkhof, J Valk, et al.
Neurology|August 1, 1991
Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosisF Barkhof, O R Hommes, P Scheltens, et al.
Journal of Neural Transmission. Supplementum|January 1, 1997
rCBF SPECT in Parkinson's disease patients with mental dysfunctionS Bissessur, G Tissingh, E C Wolters, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 12, 1992
[The value of new diagnostic techniques in Alzheimer's disease]P Scheltens, H C Weinstein, W A van Gool
Psychiatry Research|August 31, 1999
Visual assessment of medical temporal lobe atrophy in demented and healthy control subjects: correlation with volumetryL O Wahlund, P Julin, J Lindqvist, et al.
Pageof 27

Showing results (31-40 of 266) with videos related to

Sort By:
Pageof 27
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1994
Visual rating of hippocampal atrophy: correlation with volumetryP Vermersch, D Leys, P Scheltens, et al.
Acta Neurologica Scandinavica|September 1, 1990
A Dutch family with autosomal dominant pure spastic paraparesis (Strümpell's disease)P Scheltens, R P Bruyn, G J Hazenberg
Journal of Neurology, Neurosurgery, and Psychiatry|August 19, 2005
Progression of cerebral white matter lesions in Alzheimer's disease: a new window for therapy?F-E de Leeuw, F Barkhof, P Scheltens
European Journal of Neurology|August 8, 2009
Use of cerebrospinal fluid biomarkers in diagnosis of dementia across EuropeJ Hort, A Bartos, T Pirttilä, et al.
AJNR. American Journal of Neuroradiology|January 1, 1992
Meningeal Gd-DTPA enhancement in multiple sclerosisF Barkhof, J Valk, O R Hommes, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 19, 1990
[Vascular dementia]P Scheltens, F Barkhof, J Valk, et al.
Neurology|August 1, 1991
Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosisF Barkhof, O R Hommes, P Scheltens, et al.
Journal of Neural Transmission. Supplementum|January 1, 1997
rCBF SPECT in Parkinson's disease patients with mental dysfunctionS Bissessur, G Tissingh, E C Wolters, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 12, 1992
[The value of new diagnostic techniques in Alzheimer's disease]P Scheltens, H C Weinstein, W A van Gool
Psychiatry Research|August 31, 1999
Visual assessment of medical temporal lobe atrophy in demented and healthy control subjects: correlation with volumetryL O Wahlund, P Julin, J Lindqvist, et al.
Pageof 27